Market Research & Insights
Workforce gaps in Australian MedTech, Pharma, Biotech and digital health sectors

Australia’s medical technology, biotechnology, pharmaceutical and digital health sector supports approximately 70,000 Australian jobs and contributed more than $5 billion in Gross Value Added (GVA) to the Australian economy in 2019. Its future is dependent on the skills of its workforce.
Earlier this year, MTPConnect set out to better understand the sector’s workforce needs and skills gaps by funding some sector research.
Working with the support of a cross-industry project team of AusBiotech, ANDHealth, Medical Technology Association of Australia (MTAA) and Medicines Australia, an online survey of human resource (HR) professionals and managers with hiring responsibilities in the sector was developed to find out more.
The results of the survey are in and BehaviourWorks Australia, a research enterprise within the Monash Sustainable Development Institute has prepared the following report, ‘A Survey of Workforce Skills and Capacity in the Medical Technology, Biotechnology, Pharmaceutical and Digital Health (MTP) Sector’.
This report identifies current, emerging and future skills gaps that need to be addressed in order to drive employment and growth in the Australian MTP sector, including:
- Business skills and commercial expertise
- Regulation and quality
- Clinical (including trials)
- Biological sciences and technologies
- Informatics, computation, mathematical and statistics and;
- Chemical science
Feedback concerning the lack of real-world experience in industry shows there is more work to be done to support career development opportunities in our sector.
These survey results have now been incorporated into a comprehensive Skills Gap Analysis being undertaken by L.E.K for MTPConnect’s REDI program.
REDI is a four-year $32 million MRFF funded program which aims to build the MTP workforce, address skills gaps and enhance entrepreneurship in Australia. An interim Skills Gap Analysis report will be released next month.
News - MedTech & Diagnostics
Another talkfest? NSW Preventive Health Summit faces test of political will
Six days before the NSW Government’s invitation-only Preventive Health Summit, the state’s major political parties have put competing prevention policies […]
MoreNews - Pharmaceuticals
Oncologists urge global expansion of Australia’s landmark pan-tumour funding
Two international oncologists are calling on health systems in the United States and Europe to follow Australia’s lead after the […]
MoreNews - Pharmaceuticals
TGA backs Roche implant as first-of-its-kind anti-VEGF therapy for wet AMD
The Therapeutic Goods Administration (TGA) has approved Roche’s anti-VEGF eye treatment Susvimo (ranibizumab) for use with the Contivue implant, introducing […]
MoreNews - MedTech & Diagnostics
Coalition pledges surgery backlog fix as Labor’s 12-year VIC reign faces end
Victorian Opposition Leader Jess Wilson has unveiled the Surgery Sooner policy as one of the Coalition’s health pledges ahead of […]
More